Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003

被引:102
作者
Tanaka, Hideo
Imai, Yasuharu
Hiramatsu, Naoki
Ito, Yuri
Imanaka, Kazuho
Oshita, Masahide
Hijioka, Taizo
Katayama, Kazuhiro
Yabuuchi, Iwao
Yoshihara, Harumasa
Inoue, Atsuo
Kato, Michio
Takehara, Tetsuo
Tamura, Shinji
Kasahara, Akinori
Hayashi, Norio
Tsukuma, Hideaki
机构
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[2] Ikeda Municipal Hosp, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Osaka, Japan
[4] Osaka Police Hosp, Osaka, Japan
[5] Natl Hosp Org Osaka Minami Med Ctr, Osaka, Japan
[6] Osaka Koseinenkin Hosp, Osaka, Japan
[7] Otemae Hosp, Osaka, Japan
[8] Ossaka Rousai Hosp, Osaka, Japan
[9] Osaka Gen Med Ctr, Osaka, Japan
[10] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan
关键词
D O I
10.7326/0003-4819-148-11-200806030-00004
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Japan has the highest incidence rate of primary liver cancer attributed to chronic hepatitis C virus (HCV) infection among developed countries. Molecular clock analysis of HCV sequences revealed that the spread of HCV took place earlier in Japan than in other countries. This might influence recent temporal trends in hepatocellular carcinoma (HCC) incidence. Objective: To characterize the contribution of HCV-related hepatocellular carcinoma (HCC) to recent changes in HCC incidence in Osaka, Japan. Design: Population-based survey. Setting: Osaka Cancer Registry and 10 hospitals in Osaka. Participants: 63 862 patients with HCC that was diagnosed between 1981 and 2003 in Osaka Prefecture, including 5253 HCV-seropositive patients with HCC that was diagnosed between 1990 and 2003 at 10 hospitals. Measurements: Incidence of HCC and estimated incidence rate of HCV-related HCC, measured by multiplying the prevalence of anti-HCV by the corresponding HCC incidence rate. Results: Between 1981 and 2003, peak incidence of HCC among men age 50 to 59 years, 60 to 69 years, and 70 to 79 years occurred in 1986, 1995, and 2000, respectively, with marked downward trends thereafter (average annual change, -7.9, -22.3, and -12.4 per 100 000 persons, respectively). Similar trends were observed in women. Estimated sex- and age-specific incidence of HCV-related HCC (per 100 000 persons) decreased from 255 to 92 cases at the maximum in men age 60 to 69 years and from 61 to 34 cases in women age 60 to 69 years, whereas estimated incidence of non-HCV-related HCC did not change between 1990 and 2003. Limitation: Infection was determined only by HCV seropositivity. Conclusion: The incidence of HCC in Osaka started to decrease by 2000, mainly because of decreased HCV-related HCC.
引用
收藏
页码:820 / U29
页数:8
相关论文
共 31 条
[1]
Ajiki W, 2000, JPN J CLIN ONCOL, V30, P318
[2]
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study [J].
Davila, JA ;
Morgan, RO ;
Shaib, Y ;
McGlynn, KA ;
El-Serag, HB .
GASTROENTEROLOGY, 2004, 127 (05) :1372-1380
[3]
The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update [J].
El-Serag, H ;
Davila, JA ;
Petersen, NJ ;
McGlynn, KA .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) :817-823
[4]
Risk factors for the rising rates of primary liver cancer in the United States [J].
El-Serag, HB ;
Mason, AC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) :3227-3230
[5]
Ferlay J., 2001, GLOBOCAN 2000 CANC I
[6]
Fritz A, 2000, International classification of diseases for oncology, V3rd
[7]
Iida F, 1999, B WORLD HEALTH ORGAN, V77, P573
[8]
Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C [J].
Imai, Y ;
Kawata, S ;
Tamura, S ;
Yabuuchi, I ;
Noda, S ;
Inada, M ;
Maeda, Y ;
Shirai, Y ;
Fukuzaki, T ;
Kaji, I ;
Ishikawa, H ;
Matsuda, Y ;
Nishikawa, M ;
Seki, K ;
Matsuzawa, Y .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (02) :94-99
[9]
Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO
[10]
2-Z